1 Min Read
Feb 10 (Reuters) - Vectura Group PLC : * Norwegian regulatory authority confirm approval of airflusal forspiro * Treatment is new inhaler for patients with asthma and chronic obstructive
pulmonary disease (copd). * Source text
All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.
© 2017 Reuters. All Rights Reserved.